Klee Justin B.
Amylyx Pharmaceuticals, Inc. · Co-Chief Executive Officer
Klee Justin B. is listed in filings as Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including sale activity. Recent filings connect the profile to Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Oct 2, 2024 to Mar 9, 2026. Reported amounts are shown as $59.4K to $30.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $59k18.6k shares | SellSep 30, 2024 | $3.20 | $17.02 | |
| $30k7.5k shares | SellJan 6, 2025 | $4.04 | $17.02 | |
| $41k11.9k shares | SellFeb 3, 2025 | $3.47 | $17.02 | |
| $14k4.6k shares | SellMar 3, 2025 | $3.15 | $17.02 | |
| $74k21.5k shares | SellMar 31, 2025 | $3.46 | $17.02 | |
| $3k200 shares | SellSep 30, 2025 | $15.01 | $17.02 | |
| $428k29.8k shares | SellSep 30, 2025 | $14.37 | $17.02 | |
| $86k7.7k shares | SellJan 6, 2026 | $11.09 | $17.02 | |
| $2M136.2k shares | SellJan 15, 2026 | $13.58 | $17.02 | |
| $28k2k shares | SellJan 16, 2026 | $13.89 | $17.02 | |
| $228k15.5k shares | SellFeb 2, 2026 | $14.69 | $17.02 |